Targeting mGlyR with nanobodies for depression

Development of therapies for neuropsychiatric conditions is one of the greatest challenges of modern medicine. Common limitations of traditional small molecule drugs include poor efficacy, off-target side effects and difficult druggability of many targets. In this study, we report a different approach deploying small engineered single domain antibodies, known as nanobodies, for the treatment of depression, a prevalent neuropsychiatric condition. We develop highly selective nanobodies for a recently discovered glycine receptor mGlyR crucially linked to pathophysiology of depression. Using a mouse model of stress-induced depression, we show that non-invasive intranasal delivery of nanobody produces rapid and lasting anti-depressant effect. We solve an atomic structure of mGlyR bound to nanobody and use a variety of cell-based approaches to reveal the mechanism of mGlyR modulation and its impact on neural circuitry. These findings support development of biologics for the treatment of intractable brain disorders.

Authors

Institutions

Publication Details

Journal
Nature Communications
Published
2026-01-26
DOI
https://doi.org/10.1038/s41467-026-68339-x
Primary Topic
Monoclonal and Polyclonal Antibodies Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Targeting mGlyR with nanobodies for depression

Gloria Brunori, Kirill A. Martemyanov, Christoph Rader, Thibaut Laboute et al.
Nature Communications
Monoclonal and Polyclonal Antibodies Research
article

Targeting mGlyR with nanobodies for depression

Gloria Brunori, Kirill A. Martemyanov, Christoph Rader, Thibaut Laboute, Haiyong Peng, Appu K. Singh, Shikha Singh, Mansi Sharma, KV Nageswar, Stefano Zucca, Omar K. Sial
article en

Abstract

Development of therapies for neuropsychiatric conditions is one of the greatest challenges of modern medicine. Common limitations of traditional small molecule drugs include poor efficacy, off-target side effects and difficult druggability of many targets. In this study, we report a different approach deploying small engineered single domain antibodies, known as nanobodies, for the treatment of depression, a prevalent neuropsychiatric condition. We develop highly selective nanobodies for a recently discovered glycine receptor mGlyR crucially linked to pathophysiology of depression. Using a mouse model of stress-induced depression, we show that non-invasive intranasal delivery of nanobody produces rapid and lasting anti-depressant effect. We solve an atomic structure of mGlyR bound to nanobody and use a variety of cell-based approaches to reveal the mechanism of mGlyR modulation and its impact on neural circuitry. These findings support development of biologics for the treatment of intractable brain disorders.

Nature CommunicationsVol. 17(1)
Université de Tours (FR), University of Miami (US), Inserm (FR), Translational Health Science and Technology Institute (IN), University of Florida (US), Physiologie de la Reproduction et des Comportements (FR), Columbia University (US), Indian Institute of Technology Kanpur (IN)
Frederick National Laboratory for Cancer Research, Department of Biotechnology, Ministry of Science and Technology, India, Indian Council of Medical Research, Council of Scientific and Industrial Research, India, Institut National de la Santé et de la Recherche Médicale, Ministry of Education, India, Centre National de la Recherche Scientifique, Servier, Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement, National Institutes of Health, National Cancer Institute
No poverty
Openalex Percentile: Top 79%
Monoclonal and Polyclonal Antibodies Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.